Epigenetics

J. T. Pepin, H. Cardenas, Kenneth Nephew, Daniela Matei

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Ovarian cancer (OC) is characterized by complex epigenetic alterations, including aberrant DNA methylation, histone modifications, and nucleosome positioning. Advances in the sequencing technologies over the past decade have enabled deeper characterization of the chromatin landscape in cancer. Alterations of the epigenome have been implicated in tumor progression, development of chemotherapy resistance, persistence, and survival of cancer stem cells. As the machinery governing epigenetic changes is being deciphered, the OC epigenome will become an important new therapeutic cancer target.

Original languageEnglish (US)
Title of host publicationTranslational Advances in Gynecologic Cancers
PublisherElsevier Inc.
Pages35-58
Number of pages24
ISBN (Electronic)9780128037980
ISBN (Print)9780128037416
DOIs
StatePublished - Feb 22 2017

Fingerprint

Epigenomics
Ovarian Neoplasms
Histone Code
Neoplasms
Neoplastic Stem Cells
Nucleosomes
DNA Methylation
Chromatin
Technology
Drug Therapy
Therapeutics

Keywords

  • DNA methylation
  • Epigenome
  • Histone modifications
  • Ovarian cancer

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pepin, J. T., Cardenas, H., Nephew, K., & Matei, D. (2017). Epigenetics. In Translational Advances in Gynecologic Cancers (pp. 35-58). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-803741-6.00003-3

Epigenetics. / Pepin, J. T.; Cardenas, H.; Nephew, Kenneth; Matei, Daniela.

Translational Advances in Gynecologic Cancers. Elsevier Inc., 2017. p. 35-58.

Research output: Chapter in Book/Report/Conference proceedingChapter

Pepin, JT, Cardenas, H, Nephew, K & Matei, D 2017, Epigenetics. in Translational Advances in Gynecologic Cancers. Elsevier Inc., pp. 35-58. https://doi.org/10.1016/B978-0-12-803741-6.00003-3
Pepin JT, Cardenas H, Nephew K, Matei D. Epigenetics. In Translational Advances in Gynecologic Cancers. Elsevier Inc. 2017. p. 35-58 https://doi.org/10.1016/B978-0-12-803741-6.00003-3
Pepin, J. T. ; Cardenas, H. ; Nephew, Kenneth ; Matei, Daniela. / Epigenetics. Translational Advances in Gynecologic Cancers. Elsevier Inc., 2017. pp. 35-58
@inbook{b10bb056c6ff400fb5e43f699308669f,
title = "Epigenetics",
abstract = "Ovarian cancer (OC) is characterized by complex epigenetic alterations, including aberrant DNA methylation, histone modifications, and nucleosome positioning. Advances in the sequencing technologies over the past decade have enabled deeper characterization of the chromatin landscape in cancer. Alterations of the epigenome have been implicated in tumor progression, development of chemotherapy resistance, persistence, and survival of cancer stem cells. As the machinery governing epigenetic changes is being deciphered, the OC epigenome will become an important new therapeutic cancer target.",
keywords = "DNA methylation, Epigenome, Histone modifications, Ovarian cancer",
author = "Pepin, {J. T.} and H. Cardenas and Kenneth Nephew and Daniela Matei",
year = "2017",
month = "2",
day = "22",
doi = "10.1016/B978-0-12-803741-6.00003-3",
language = "English (US)",
isbn = "9780128037416",
pages = "35--58",
booktitle = "Translational Advances in Gynecologic Cancers",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Epigenetics

AU - Pepin, J. T.

AU - Cardenas, H.

AU - Nephew, Kenneth

AU - Matei, Daniela

PY - 2017/2/22

Y1 - 2017/2/22

N2 - Ovarian cancer (OC) is characterized by complex epigenetic alterations, including aberrant DNA methylation, histone modifications, and nucleosome positioning. Advances in the sequencing technologies over the past decade have enabled deeper characterization of the chromatin landscape in cancer. Alterations of the epigenome have been implicated in tumor progression, development of chemotherapy resistance, persistence, and survival of cancer stem cells. As the machinery governing epigenetic changes is being deciphered, the OC epigenome will become an important new therapeutic cancer target.

AB - Ovarian cancer (OC) is characterized by complex epigenetic alterations, including aberrant DNA methylation, histone modifications, and nucleosome positioning. Advances in the sequencing technologies over the past decade have enabled deeper characterization of the chromatin landscape in cancer. Alterations of the epigenome have been implicated in tumor progression, development of chemotherapy resistance, persistence, and survival of cancer stem cells. As the machinery governing epigenetic changes is being deciphered, the OC epigenome will become an important new therapeutic cancer target.

KW - DNA methylation

KW - Epigenome

KW - Histone modifications

KW - Ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=85027153586&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027153586&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-803741-6.00003-3

DO - 10.1016/B978-0-12-803741-6.00003-3

M3 - Chapter

SN - 9780128037416

SP - 35

EP - 58

BT - Translational Advances in Gynecologic Cancers

PB - Elsevier Inc.

ER -